MiR-17-5p inhibits cerebral hypoxia/reoxygenationinjury by targeting PTEN through regulation of PI3K/AKT/mTOR signaling pathway

References

• Caldeira MV, Salazar IL, Curcio M, et al. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe? Prog Neurobiol. 2014;112(1):50–69.
   PubMed Web of Science ®Google Scholar
• Wmr A, Al-Anwar AD, Kamel AE, et al. Predictors of early infection in cerebral ischemic stroke. J Med Life. 2016;9(2):163–169.
   PubMedGoogle Scholar
• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2015 update. Circulation. 2015;131:CIR.0000000000000350.
   Web of Science ®Google Scholar
• Stecksén A, Glader EL, Asplund K, et al. Education level and inequalities in stroke reperfusion therapy: observations in the Swedish stroke register. Stroke. 2014;45(9):2762–2768.
   PubMed Web of Science ®Google Scholar
• Su D, Ma J, Zhang Z, et al. Protective effects of UCF-101 on cerebral ischemia–reperfusion (CIR) is depended on the MAPK/p38/ERK signaling pathway. Cell Mol Neurobiol. 2016;36(6):907–914.
   PubMed Web of Science ®Google Scholar
• Datta G, Fuller BJ, Davidson BR. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models . World J Gastroenterol. 2013;19(11):1683–1698.
   PubMed Web of Science ®Google Scholar
• Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460–469.
   PubMed Web of Science ®Google Scholar
• Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13(8):622–638.
   PubMed Web of Science ®Google Scholar
• Weiss JB, Eisenhardt SU, Stark GB, et al. MicroRNAs in ischemia-reperfusion injury. Am J Cardiovasc Dis. 2012;2(3):237–247.
   PubMedGoogle Scholar
• Varga ZV, Zvara A, Faragó N, et al. MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs. Am J Physiol Heart Circ Physiol. 2014;307(2):H216–H227.
   PubMed Web of Science ®Google Scholar
• Di Y, Lei Y, Yu F, et al. MicroRNAs expression and function in cerebral ischemia reperfusion injury. J Mol Neurosci. 2014;53(2):242–250.
   PubMed Web of Science ®Google Scholar
• Shi J, Bei Y, Kong X, et al. miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury. Theranostics. 2017;7(3):664–676.
   PubMed Web of Science ®Google Scholar
• Hao J, Wei Q, Mei S, et al. Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. Kidney Int. 2017;91(1):106–118.
   PubMed Web of Science ®Google Scholar
• Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol. 2004;15(2):177–182.
   PubMed Web of Science ®Google Scholar
• Yu L, Li F, Zhao G, et al. Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling. Apoptosis. 2015;20(6):796–810.
   PubMed Web of Science ®Google Scholar
• Yang YK, Xi WY, Xi RX, et al. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN. Oncol Rep. 2015;33(5):2393–2401.
   PubMed Web of Science ®Google Scholar
• Cao C, Subhawong T, Albert JM, et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 2006;66(20):10040–10047.
   PubMed Web of Science ®Google Scholar
• Wu YR, Qi HJ, Deng DF, et al. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol. 2016;37(9):12061– 12010.
   PubMedGoogle Scholar
• Ke ZP, Peng X, Yan S, et al. MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN. Oncotarget. 2016;7(20):28796–28805.
   PubMedGoogle Scholar
• Kamo N, Ke B, Busuttil RW, et al. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury. Hepatology. 2013;57(1):289–298.
   PubMed Web of Science ®Google Scholar
• Shan SW, Fang L, Shatseva T, et al. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci. 2013;126(Pt 6):1517–1530.
   PubMed Web of Science ®Google Scholar
• Di C, Dixon BJ, Doycheva DM, et al. IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats. J Neuroinflammation. 2018;15(1):32
   PubMed Web of Science ®Google Scholar
• Tu Y, Lin W, Fan Y, et al. Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. Plos One. 2013;8(10):e75872
   PubMed Web of Science ®Google Scholar
• Yue S, Rao J, Zhu J, et al. Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation. J Immunol. 2014;192(11):5343–5353.
   PubMed Web of Science ®Google Scholar
• Wu SY, Wu AT, Yuan KS, et al. Brown seaweed fucoidan inhibits cancer progression by dual regulation of mir-29c/ADAM12 and miR-17-5p/PTEN axes in human breast cancer cells. J Cancer. 2016;7(15):2408–2419.
   PubMed Web of Science ®Google Scholar
• Fang L, Li H, Wang L, et al. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget. 2014;5(10):2974–2987.
   PubMedGoogle Scholar
• Li W, Yang Y, Hu Z, et al. Neuroprotective effects of DAHP and triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation. Front Neuroanat. 2015;9:48. DOI:https://doi.org/10.3389/fnana.2015.00048
   PubMed Web of Science ®Google Scholar
• Li Q, Shen L, Wang Z, et al. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway. Biomed Pharmacother. 2016;84:106–114.
   PubMed Web of Science ®Google Scholar
• Hu S, Zhang Y, Zhang M, et al. Aloperine protects mice against ischemia reperfusion (IR)-induced renal injury by regulating PI3K/AKT/mTOR signaling and AP-1 activity. Mol Med. 2015;21(1):912–923.
   PubMed Web of Science ®Google Scholar